Social networking analysis helps identify cancer biomarkers

June 4, 2015, Inderscience Publishers

The advent of online social networks has led to the rapid development of tools for understanding the interactions between members of the network, their activity, the connections, the hubs and nodes. But, any relationships between lots of entities, whether users of Facebook and Twitter, bees in a colony, birds in a flock, or the genes and proteins in our bodies can be analyzed with the same tools.

Now, research published in International Journal of Data Mining and Bioinformatics shows how social network analysis can be used to understand and identify the biomarkers in our bodies for diseases, including different types of cancer.

Tansel Özyer, Serkan Ucer and Taylan Iyidogan of the Department of Computer Engineering, at TOBB University, in Ankara, Turkey, explain how the detection of disease biomarkers in general and in particular has become an important task in medical research and diagnostics. They have now used the tools of Social Network Analysis (SNA) to help them unravel the connections and identify the biomarkers present in patient genomic microarray data.

By analogy with a social network, the team views genes as actors or members of the social network and similarities between different genes are considered to be the connections between these actors. Genomic databases can be vast, given that the human genome comprises some 20000 genes, and so such an approach can, they suggest, dramatically decrease the number of features that must be analyzed to find useful biomarkers. Once identified and understood, such biomarkers can then be tested for in screening programs for people at risk of a given disease or for diagnosis should the present with particular symptoms.

The team has demonstrated proof of principle with three types of cancer: lymphoma, and leukemia. "We showed how our approach is capable of effectively detecting cancer out of high-dimensional genomic data," the team reports. "We combined clustering and classification into the developed framework to help in detecting the links between the various genes within the model and to validate the outcome, respectively." The next step will be to optimize the approach and to extend it to protein-protein interactions, protein-gene interactions, disease-protein interactions, disease-drug all with a view to improving diagnostics and tailoring therapy for the individual patient based on the outcomes of their personal biological network analysis.

Explore further: Researchers search for telltale signs of ovarian cancer

More information: Özyer, T., Ucer, S. and Iyidogan, T. (2015) 'Employing social network analysis for disease biomarker detection', Int. J. Data Mining and Bioinformatics, Vol. 12, No. 3, pp.343-362.

Related Stories

Researchers search for telltale signs of ovarian cancer

March 16, 2015
This year, ovarian cancer will claim over 125,000 lives worldwide. The deadly disease remains the fifth leading cause of cancer-related mortality in U.S. women, killing about 15,000 per year.

Team finds markers related to ovarian cancer survival and recurrence

April 30, 2013
(Medical Xpress)—Researchers at the University of Illinois have identified biomarkers that can be used to determine ovarian cancer survival and recurrence, and have shown how these biomarkers interact with each other to ...

Largest-ever map of the human interactome predicts new cancer genes

November 20, 2014
Scientists have created the largest-scale map to date of direct interactions between proteins encoded by the human genome and newly predicted dozens of genes to be involved in cancer.

Researchers open 'Pandora's box' of potential cancer biomarkers

January 20, 2015
A new analysis opens the door to discovery of thousands of potential new cancer biomarkers.

Pseudogenes may provide clearer understanding of biomarkers

July 7, 2014
Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival ...

Genetics and lifestyle have a strong impact on biomarkers for inflammation and cancer

August 22, 2014
In a new study published in Nature Communications, research scientists from Uppsala University present for the first time a large-scale study of the significance of genetic, clinical and lifestyle factors for protein levels ...

Recommended for you

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.